4D Molecular Therapeutics Rings the Nasdaq Stock Market Closing Bell
Alpha Vantage · Nasdaq · · AI-summarised by FinFlash
4D Molecular Therapeutics (Nasdaq: FDMT), a late-stage biotechnology company, visited the Nasdaq MarketSite in Times Square for a bell ceremony. David Kirn, M.D., Co-founder, President, and CEO, rang the Closing Bell to commemorate the occasion. This event is part of Nasdaq's regular market opening and closing ceremonies held in Times Square and globally.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.